Nexalin Technology (NXL) Operating Margin (2021 - 2026)
Nexalin Technology (NXL) posted quarterly Operating Margin of 14179.95% for Q1 2026, down 927631.0% year-over-year from N/an in Q1 2025, and down 910.07% quarter-over-quarter from 1403.86% in Q4 2025.
Nexalin Technology (NXL) Operating Margin (2021 - 2026) Analysis & Trends
Nexalin Technology's Operating Margin history runs 6 years deep, the most recent figure standing at 14179.95% for Q1 2026.
- In Q1 2026, Operating Margin fell 927631.0% year-over-year to 14179.95%; the TTM figure through Mar 2026 stood at 3084.22% (up 354772.0% YoY), while the FY2025 annual figure was 2781.69%, up 181445.0% from the prior year.
- Operating Margin for Q1 2026 stood at 14179.95%, down from 1403.86% in the prior quarter.
- The five-year high for Operating Margin was 53.77% in Q3 2022, with the low at 14179.95% in Q1 2026.
- The 5-year median for Operating Margin is 2550.48% (2023), against an average of 4973.09%.
- The sharpest annual moves came in 2023 and 2025: Operating Margin tumbled 996381 bps in 2023, then soared 917562 bps in 2025.
- Nexalin Technology's Operating Margin stood at 1872.83% in 2022, then tumbled by 322 bps to 7910.37% in 2023, then sank by 34 bps to 10579.48% in 2024, then soared by 87 bps to 1403.86% in 2025, then plunged by 910 bps to 14179.95% in 2026.
- Business Quant data shows NXL's Operating Margin at 14179.95% in Q1 2026, 1403.86% in Q4 2025, and 12924.3% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 19.15% |
| 10 | Nexalin Technology | 6.98 Mn | 5.97 Mn | 8,897.00 | -18,479.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -18,479.69% |
| Mar 31, 2026 | -14,179.95% |
| Dec 31, 2025 | -1,403.86% |
| Sep 30, 2025 | -12,924.30% |
| Jun 30, 2025 | -2,296.22% |
| Mar 31, 2025 | -4,903.63% |
| Dec 31, 2024 | -10,579.48% |
| Sep 30, 2024 | -6,962.11% |
| Jun 30, 2024 | -4,832.42% |
| Mar 31, 2024 | -1,364.81% |
| Dec 31, 2023 | -7,910.37% |
| Sep 30, 2023 | -10,017.57% |
| Jun 30, 2023 | -2,467.25% |
| Mar 31, 2023 | -2,550.48% |
| Dec 31, 2022 | -1,872.83% |
| Sep 30, 2022 | -53.77% |
| Jun 30, 2022 | -107.44% |
| Mar 31, 2022 | -116.02% |
| Dec 31, 2021 | -2,406.30% |
| Sep 30, 2021 | -3,207.88% |